Search Results 331-340 of 17558 for metformin
On a stable (for the last 3 months prior to screening) regimen of metformin monotherapy equivalent of at least 1000 mg once daily. Males, females of ...
Linagliptin; Liraglutide; Metformin; Metoclopramide; Metreleptin; Miglitol; Nateglinide; Octreotide Acetate; Pasireotide Diaspartate; Pioglitazone; Pramlintide ...
The researchers further hypothesize that a well-studied insulin sensitizing agent, Metformin, can be administered to overcome these effects and ...
Aspirin, Other NSAIDS, Metformin and Statins in Biliary Tract Cancer Risk and Survival: A Swedish Population-Based Cohort Study. Undergraduate. B.S., Cellular ...
- Use of anti-obesity medications upon screening (i.e., orlistat, phentermine-topiramate, liraglutide, semaglutide, bupropion-naltrexone), metformin or GLP-1 ...
Metformin; Metoclopramide; Metreleptin; Miglitol; Moxifloxacin; Nateglinide; Norfloxacin; Octreotide Acetate; Ofloxacin; Orlistat; Pasireotide Diaspartate. Show ...
Description. Letrozole is used to treat certain types of breast cancer in women who have already stopped menstruating (postmenopausal).
Use of any glucose-lowering agents including metformin or sulfonylureas. For female subjects: positive pregnancy test at the time of enrollment or study ...
... metformin, acarbose or DPP-4 inhibitors (e.g. sitagliptin and vildagliptin). Past or current history of pancreatitis, gallstones, history of alcoholism ...
Metformin hydrochloride may help paclitaxel and carboplatin work better by making cancer cells more sensitive to the drugs. It is not yet known whether ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!